Share this article
Share this article
ALHAMBRA, Calif., March 10, 2021 /PRNewswire/ Apollo Medical Holdings, Inc. ( ApolloMed, and together with its subsidiaries and affiliated entities, the Company ) (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare management company, today announced its consolidated financial results for the fourth quarter and year ended December 31, 2020.
Financial Highlights for the Fourth Quarter and Year Ended December 31, 2020:
Company exceeded all previously disclosed guidance metrics for full-year 2020 (revenue, net income, EBITDA, and adjusted EBITDA)
Total revenue of $687.2 million for the year ended December 31, 2020, up 23% from $560.6 million for the prior year
Net income of $122.3 million for the year ended December 31, 2020, from $17.7 million for the prior year
Share this article
Share this article
ALHAMBRA, Calif., March 2, 2021 /PRNewswire/ Apollo Medical Holdings, Inc. ( ApolloMed, and together with its subsidiaries and affiliated entities, the Company ) (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare management company, today announced the appointment of Jeremy R. Jackson, M.D., to the newly created role of Chief of Staff, effective March 10, 2021.
In his role as Chief of Staff, Dr. Jackson will work closely with the executive team and play a key role in special projects for ApolloMed s technology platform, business development, strategy and operations.
Dr. Jackson brings 10 years of healthcare industry experience in management consulting and as a practicing physician to ApolloMed. He previously served as a Project Leader in the Boston Consulting Group s healthcare practice and, from 2011 to 2018, was a resident physician in the Department of General Surgery at Brigham and Women s Hospital (Harvard Me